Robuta

https://www.neurosurgeryone.com/provider-blog/drug-resistant-epilepsy-patient-surgery-criteria/ Drug-Resistant Epilepsy Patients Face 20-Year Delay in Surgery Referral - Neurosurgery One Oct 12, 2026 - For patients with epilepsy that haven't seen results with medication, providers should consider referring them for surgical evaluation. drug resistant epilepsypatientsfaceyeardelay https://givingcompass.org/article/new-drug-trial-gives-hope-for-treatment-resistant-epilepsy New Drug Trial Gives Hope for Treatment-Resistant Epilepsy - Giving Compass Apr 8, 2019 - According to Lindsay Kurs at On the Pulse, a new drug trial at Seattle Children's Hospital has sparked hope for treatment-resistant epilepsy. new drugtrialgiveshopetreatment https://theweedblog.com/medical/first-ever-cannabis-based-epilepsy-drug-is-not-going-to-be-cheap First Ever Cannabis-Based Epilepsy Drug is Not Going to Be Cheap - The Weed Blog Dec 20, 2025 - The first cannabis-based epilepsy drug, Epidiolex, has FDA approval, but the cost is $32,500 per year. Discover if this new drug is affordable. first everepilepsy drugis notgoing tocannabis https://www.diwou.com/2025/09/11/zhimeng-biopharmas-investigational-drug-approved-to-initiate-phase-2-epilepsy-clinical-trial-in-china/ Zhimeng Biopharma's Investigational Drug Approved to Initiate Phase 2 Epilepsy Clinical Trial in... Sep 11, 2025 - SHANGHAI, Sept. 12, 2025 /PRNewswire/ — Shanghai Zhimeng Biopharma, Inc. (“Zhimeng Biopharma”) announced that its self-developed novel next-generation KCNQ2/3... investigational drugclinical trialbiopharmaapprovedinitiate https://lingoexp.com/release/2026103089.html Epilepsy Drug Market Research Report: Market Growth, Industry Trends and Forecast 2035 - LingoExp Sep 20, 2026 - The Epilepsy Drug Market focuses on medicines and therapeutic approaches used to control epileptic seizures and manage e... epilepsy drugmarket researchgrowth industryreporttrends https://mediccanna.com/news/gw-pharmas-cannabis-based-epilepsy-drug-meets-main-goal-in-a-late-stage-trial/ GW Pharma’s cannabis-based epilepsy drug meets main goal in a late-stage trial – Mediccanna epilepsy drugin alate stagecannabisbased https://www.ddw-online.com/neumirna-and-ten23-partner-to-advance-epilepsy-treatments-38355-202510/ Neumirna and ten23 partner to advance epilepsy treatments - Drug Discovery World (DDW) drug discoverypartneradvanceepilepsytreatments https://www.thedailyheadache.com/tag/epilepsy-drug epilepsy drug Archives - The Daily Headache epilepsy drugthe dailyarchivesheadache https://www.cureepilepsy.org/news/does-the-accumulated-antiepileptic-drug-load-in-chronic-epilepsy-reflect-disease-severity/ Does the Accumulated Antiepileptic Drug Load in Chronic Epilepsy Reflect Disease Severity? – CURE... Does the Accumulated Antiepileptic Drug Load in Chronic Epilepsy Reflect Disease Severity?October 16, 2020Abstract, originally published in EpilepsiaObjecti... antiepileptic drugaccumulatedloadchronicepilepsy https://www.cgtlive.com/view/exploring-cell-therapy-treatment-drug-resistant-epilepsy Exploring Cell Therapy for the Treatment of Drug-Resistant Epilepsy | CGTlive® Oct 6, 2026 - Cory Nicholas, PhD, cofounder and chief executive officer, Neurona Therapeutics, discussed the company’s lead program in mesial temporal lobe epilepsy. drug resistant epilepsycell therapyexploringtreatment https://www.cureepilepsy.org/news/therapy-that-targets-underlying-cause-of-dravet-syndrome-gets-orphan-drug-status/ Therapy That Targets Underlying Cause of Dravet Syndrome Gets Orphan Drug Status – CURE Epilepsy Jun 18, 2024 - Therapy That Targets Underlying Cause of Dravet Syndrome Gets Orphan Drug StatusAugust 8, 2019The FDA has granted Orphan Drug designation to STK-001 (Stoke T... orphan drug statusdravet syndrometherapytargetsunderlying https://www.trialx.com/clinical-trials/listings/225798/low-intensity-focused-ultrasound-6/ Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial | Clinical Research Trial Listing ( Drug... Clinical trial for Drug Resistant Epilepsy , Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial focused ultrasoundpilot trialclinical researchlowintensity https://warriortradingnews.com/2019/08/07/marijuana-based-epilepsy-drug-sales-double-gw-pharma-stock-soaring/ Marijuana-based epilepsy drug sales double, GW Pharma stock soaring - Warrior Trading News Sep 23, 2019 - GW Pharma (NASDAQ: GWPH) saw its shares jumped by over 12 percent on Tuesday when it announced that sales of its child-epilepsy drug, Epidiolex, more than... epilepsy drugmarijuanabasedsalesdouble https://clinicstree.com/epilepsy-surgery-kathmandu Epilepsy Surgery Evaluation in Kathmandu — Drug-Resistant Epilepsy Options | Kathmandu Neurology... Epilepsy surgery evaluation Kathmandu: presurgical assessment for drug-resistant epilepsy by Dr. Jitendra Prasad Yadav (NMC 8029). 15+ years, National Trauma... epilepsy surgerydrug resistantevaluationkathmanduoptions https://scienceblog.com/cannabis-based-drug-reduces-seizures-in-children-with-treatment-resistant-epilepsy/ Cannabis-Based Drug Reduces Seizures in Children With Treatment Resistant Epilepsy - ScienceBlog.com Jul 20, 2026 - Children and young adults with severe forms of epilepsy that does not respond to standard antiepileptic drugs have fewer seizures when treated with… in childrencannabisbaseddrugreduces https://recherche.chu-lyon.fr/epiarousal EPIAROUSAL : Arousal and respiratory co-dysfunction in drug-resistant epilepsy: from mechanisms to... EPIAROUSAL est un projet européen mené par le Pr Sylvain RHEIMS, coordonné par l'université Lyon 1 Claude Bernard (UCBL). L'objectif est de valider que... drug resistant epilepsyarousalrespiratorydysfunctionmechanisms https://www.cureepilepsy.org/news/drug-shows-promise-in-reducing-seizures-in-those-with-severe-epilepsy/ Drug Shows Promise in Reducing Seizures in Those with Severe Epilepsy – CURE Epilepsy Jun 18, 2024 - Drug Shows Promise in Reducing Seizures in Those with Severe EpilepsyMarch 11, 2020Featuring the work of former CURE Grantee, Dr. Angelique BordeyPeople who... drugshowspromisereducingseizures